Lexaria Bioscience Corp. — Director's Dealing 2025

May 16, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Lexaria Bioscience Corp. (LEXX)
CIK: 0001348362
Period of Report: 2025-05-15

Reporting Person: BUNKA CHRISTOPHER (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-05-15	Stock Options	$1.04	A	11000	Acquired	2030-05-15	Common Shares (11000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
common shares	373543	Direct
common shares	254412	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Options	$3	2026-04-26	Common Shares (26000)	26000	Direct
Stock Options	$3	2026-06-08	Common Shares (23334)	49334	Direct
Stock Options	$3	2026-09-01	Common Shares (15000)	64334	Direct
Stock Options	$2.91	2027-08-29	Common Shares (30000)	94334	Direct
Stock Options	$1.15	2028-10-26	Common Shares (30000)	124334	Direct
Stock Options	$2.36	2029-04-26	Common Shares (49500)	173834	Direct

Footnotes

F1: 100,000 common shares were issued as a restricted stock award that is subject to escrow provisions until July 7, 2025.